Vivos Therapeutics (VVOS) Net Cash Flow Growth (1y) (2021 - 2026)
Powered by 
Analysis
Vivos Therapeutics (VVOS) Net Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Align Technology | 11.30 Bn | 10.20 Bn | 757.43 Mn | 4,848.74% |
| 2 | Envista Holdings | 4.38 Bn | 3.26 Bn | 407.00 Mn | 398.65% |
| 3 | Dentsply Sirona | 2.27 Bn | 2.03 Bn | 493.00 Mn | 190.74% |
| 4 | Milestone Scientific | 37.81 Mn | 35.20 Mn | 1.56 Mn | 109.38% |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - | 124.62% |
| 6 | Vivos Therapeutics | 2.76 Mn | 790,007.20 | 2.95 Mn | 95.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 95.98% |
| Mar 31, 2026 | 102.07% |
| Dec 31, 2025 | -9,409.09% |
| Sep 30, 2025 | -123.80% |
| Jun 30, 2025 | -321.01% |
| Mar 31, 2025 | -505.17% |
| Dec 31, 2024 | -101.67% |
| Sep 30, 2024 | 79.52% |
| Jun 30, 2024 | 237.03% |
| Mar 31, 2024 | -72.55% |
| Dec 31, 2023 | 120.53% |
| Sep 30, 2023 | 50.39% |
| Jun 30, 2023 | 39.68% |
| Mar 31, 2023 | 156.70% |
| Dec 31, 2022 | 28.95% |
| Sep 30, 2022 | -5.98% |
| Jun 30, 2022 | -125.57% |
| Mar 31, 2022 | -48.56% |
| Dec 31, 2021 | -127.07% |
| Sep 30, 2021 | -594.41% |